Barker, A.D., Sigman, C.C., Kelloff, G.J., Hylton, N.M., Berry, D.A., and Esserman, L.J. I-SPY 2: An adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy. Clin. Pharmacol. Ther. 86: 97–100, 2009.
Bertagnolli, M.M., Eagle, C.J., Zauber, A.G., Redston, M., Breazna, A., Kim, K., Tang, J., Rosenstein, R.B., Umar, A., Bagheri, D., Collins, N.T., Burn, J., Chung, D.C., Dewar, T., Foley, T.R., Hoffman, N., Macrae, F., Pruitt, R.E., Saltzman, J.R., Salzberg, B., Sylwestrowicz, T., Hawk, E.T., and the Adenoma Prevention with Celecoxib Study Investigators. Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial. Cancer Prev. Res. 4: 310–321, 2009.
Fay, J.R., Steele, V., and Crowell, J.A. Energy homeostasis and cancer prevention: The AMP-activated protein kinase. Cancer Prev. Res. 4: 301─309, 2009.
Kelloff, G.J., Choyke, P., Coffey, D.S., Scher, H.I., Wheeler, T.M., Anderson, L., Tatum, J., Scardino, P.T., Harisinghani, M., Catalona, W.J., Eisenberger, M.A., Hussain, M.H., Larson, S.M., Marberger, M., Moul, J.W., Padhani, A., Schnall, M.D., Sullivan, D.C., Wahl, R.L., Cohen, J.K., Dahut, W.L., Dicer, A.P., Ellis, R.J., Feleppa, E.J., Frenkel, V., Getzenberg, R.H., Gumbs Petty, B., Halpern, E.J., Higley, H.R., Hruszkewycz, A.M., Jacobs, P., Jessup, J.M., Kattan, M.W., Katz, A.E., Kock, M.O., Koutcher, J.A., Kurdziel, K.A., Kurhanewicz, J., Lucia, M.S., Menard, C., Parnes, H.L., Petrick, N., Pomper, M.G., Ravizzini, G., Sheinfeld, A., Sigman, C.C., Smith, M.T., Speight, J.L., Steele, V.E., Tang, Y., Tempany, C., and Valicenti, R.K. Challenges in clinical prostate cancer: Role of imaging. AJR Am. J. Roentgenol. 192: 1455–1470, 2009.
Kelloff, G.J., Sigman, C.C., and Contag, C.H. Early detection of oral neoplasia: Watching with new eyes. Cancer Prev. Res. 2: 405–408, 2009.
Weber, W., Sigman, C.C. and Kelloff, G.J. Chapter 15: PET imaging as a biomarker. In: Wahl, R.E., ed. Principles and Practice of Positron Emission Tomography, New York: Lippincott Williams & Wilkins, 2009, pp. 702–712.
Solomon, S.D., Wittes, J., Finn, P.V., Fowler, R., Viner, J., Bertagnolli, M., Arber, N., Levin, B., Meinert, C.L., Martin, B., Pater, J.L., Goss, P.E., Lance, P., Obara, S., Chew, E.Y., Kim, J., Arndt, G., Hawk, E., for the Cross Trial Safety Assessment Group. Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: The cross trial safety analysis Circulation. 22: 117: 2104–2113, 2008.
Crowell, J.A., Steele, V.E. and Fay, J.R. Targeting the AKT protein kinase for cancer chemoprevention. Mol. Cancer Ther. 6: 2139–2148, 2007.
Doody, L.A., Sigman, C.C, and Kelloff, G.J. Intervention and chemoprevention of cancer—treatment of carcinogenesis. In: Alison, M.R. (ed.) The Cancer Handbook, 2nd ed., Chichester, UK, John Wiley & Sons, August 2007, pp. 453–473.
Kelloff, G.J. and Sigman, C.C. Assessing intraepithelial neoplasia and drug-safety in cancer preventive drug development. Nature Rev. Cancer 7: 508–518, 2007.
Kelloff, G.J., Sullivan, D.C., Baker, H., Clarke, L.P., Nordstrom, R., Tatum, J.L., Dorfman, G.S., Jacobs, P., Berg, C.D., Pomper, M.G., Birrer, M.J., Tempero, M., Higley, H.R., Gumbs Petty, B., Sigman, C.C., Maley, C., Sharma, P., Wax, A., Ginsberg, G.G., Dannenberg, A.J., Hawk, E.T., Messing, E.M., Grossman, H.B., Harisinghani, M., Bigio, I.J., Griebel, D., Henson, D.E., Fabian, C.J., Ferrara, K., Fantini, S., Schnall, M.D., Zujewski, J.A., Hayes, W., Klein, E.A., DeMarzo, A., Ocak, I., Ketterling, J.A., Tempany, C., Shtern, F., Parnes, H.L., Gomez, J., Srivastava, S., Szabo, E., Lam, S., Seibel, E.J., Massion, P., McLennan, G., Cleary, K., Suh, R., Burt, R.W., Pfeiffer, R.M., Hoffman, J.M., Roy, H.K., Wang, T., Limburg, P.J., El-Deiry, W.S., Papadimitrakopoulou, V., Hittelman, W.N., MacAulay, C., Veltri, R.W., Solomon, D., Jeronimo, J., Richards-Kortum, R., Johnson, K.A., Viner, J.L., Stratton, S.P., Rajadhyaksha, M., Dhawan, A. Workshop on imaging science development for cancer prevention and preemption. Cancer Biomark. 3: 1–33, 2007.
Kopelovich, L., Fay, J.R., Sigman, C.C. and Crowell, J.A. The mammalian target of rapamycin pathway as a potential target for cancer chemoprevention. Cancer Epidemiol. Biomarkers Prev. 16: 1330–1340, 2007.
Kelloff, .G.J., Lippman, S.M., Dannenberg, A.J., Sigman, C.C., Pearce, H.L., Reid, B.J., Szabo, E., Jordan, V.C., Spitz, M.R., Mills, G.B., Papadimitrakopoulou, V.A., Lotan, R., Aggarwal, B.B., Bresalier, R.S., Kim, J., Arun, B., Lu, K.H., Thomas, M.E, Rhodes, H.E., Brewer, M.A., Follen, M., Shin, D.M., Parnes, H.L., Siegfried, J.M., Evans, A.A., Blot, W.J., Chow, W.H., Blount, P.L., Maley, C.C., Wang, K.K., Lam, S., Lee, J.J., Dubinett, S.M., Engstrom, P.F., Meyskens, F.L., Jr., O'Shaughnessy, J., Hawk, E.T., Levin, B., Nelson, W.G., Hong, W.K. and AACR Task Force on Cancer Prevention. Progress in chemoprevention drug development: The promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer—a plan to move forward. Clin. Cancer Res. 12: 3661–3997, 2006.
El-Deiry, W. S., Sigman, C.C. and Kelloff, G. J. Imaging and oncologic drug development. J. Clin. Oncol. 24: 3261–3273, 2006.
Bertagnolli, M.M., Eagle, C.J., Zauber, A.G., Redston, M., Solomon, S.D., Kim, K.M., Tang, J., Rosenstein, R.B., Wittes, J., Corle, D., Hess, T.M. Woloj, G.M., Boisserie, F., Anderson, W.F., Viner, J.L., Bagheri, D., Burn, J., Chung, D.C., Dewar, T., Foley, T.R., Hoffman, N., Macrae, F., Pruitt, R.E., Saltzman, J.R., Salzberg, B., Sylwestrowicz, T., Gordon G.B. and Hawk, E.T. Celecoxib for the prevention of sporadic adenomas. N. Engl. J. Med. 355: 873–883, 2006.
Elmore, E., Siddiqui, S., Navidi, M., Steele, V.E. and Redpath, L. Correlation of in vitro chemopreventive efficacy data from the human epidermal cell assay with animal efficacy data and clinical trial plasma levels. J. Cell Biochem. 95: 571–588, 2005.
Fay, J.R., Crowell, J.A. and Kopelovich, L. Targeting epigenetic regulatory mechanisms in cancer chemoprevention. Expert Opin. Ther. Targets 9: 315–328, 2005.
Kelloff, G.J., Krohn, K.A., Larson, S.M., Weissleder, R., Mankoff, D.A., Hoffman, J.M., Link, J.M., Guyton, K.Z., Eckelman, W.C., Scher, H.I., O'Shaughnessy, J., Cheson, B.D., Sigman, C.C., Tatum, J.L., Mills, G.Q., Sullivan, D.C. and Woodcock J. The progress and promise of molecular imaging probes in oncologic drug development. Clin. Cancer Res. 11: 7967–7985, 2005.
Kelloff, G.J., Hoffman, J.M., Johnson, B., Scher, H.I., Siegel, B.A., Cheng, E.Y., Cheson, B.D., O'Shaughnessy, J., Guyton, K.Z., Mankoff, D.A., Shankar, L., Larson, S.M., Sigman, C.C., Schilsky, R.L. and Sullivan, D.C. Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin. Cancer Res. 11: 2785–2808, 2005.
Kelloff, G.J. and Sigman, C.C. New science-based endpoints to accelerate oncology drug development. Eur. J. Cancer 41: 491–501, 2005.
Kelloff, G.J., Hawk, E.T. and Sigman, C.C. (eds.) Cancer Chemoprevention, Vol. 2: Strategies for Cancer Chemoprevention. Totowa, N.J.: Humana Press, 2005, 534 pp.
Kelloff, G.J., Hawk, E.T. and Sigman C.C. Preface: overview of chemoprevention drug development. In: Kelloff, G.J., Hawk, E.T. and Sigman, C.C. (eds.) Cancer Chemoprevention Volume 2: Strategies for Cancer Prevention. Totowa, N.J.: Humana Press, 2005, pp. v–x.
Judy Smith, MSN, RN, AOCN; Margaret Scheitrum, RAC, CIP; David Loose; Anne Tompkins, MSN, RN; Troy Budd; Beverly Meadows, PhD, RN, OCN; Leslie Ford, MD: Division of Cancer Prevention Implementation of Federal Investigator Registry of Biomedical Informatics Research Data (FIREBIRD) abstract, Cancer Bioinformatics Grid caBIG) Annual Conference, July 20–22, 2009
Solomon, S.D., McMurray, J.J., Pfeffer, M.A., Wittes, J., Fowler, R., Finn, P., Anderson, W.F., Zauber, A., Hawk, E., Bertagnolli, M., et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N. Engl. J. Med. 352: 1071–1080, 2005.
Viner, J., Hawk, E., Richmond, E., Higley, H., and Umar, A. Opportunities and challenges for skin cancer chemoprevention. In: Kelloff, G. and Sigman, C. (eds). Cancer Chemoprevention Vol. 2: Strategies for Cancer Chemoprevention. Totowa, NJ: Humana Press, 2005, pp. 421–434.